---
title: "Phenytoin - Lennox-Gastaut Syndrome"
sidebar: mydoc_sidebar
permalink: db00252-mesh-d065768-1.html
toc: false 
---


Path ID: `DB00252_MESH_D065768_1`
{% include image.html url="images/db00252-mesh-d065768-1.png" file="db00252-mesh-d065768-1.png" alt="db00252-mesh-d065768-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D010672 | Phenytoin | Drug |
| UniProt:Q14524 | Sodium channel protein type 5 subunit alpha | Protein |
| MESH:D012964 | Sodium | ChemicalSubstance |
| UBERON:0001384 | Primary motor cortex | GrossAnatomicalStructure |
| GO:0099611 | Action potential firing threshold | BiologicalProcess |
| HP:0001250 | Seizure | PhenotypicFeature |
| MESH:D065768 | Lennox-Gastaut syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Phenytoin | DECREASES ACTIVITY OF | Sodium Channel Protein Type 5 Subunit Alpha |
| Sodium Channel Protein Type 5 Subunit Alpha | INCREASES TRANSPORT OF | Sodium |
| Sodium | LOCATED IN | Primary Motor Cortex |
| Primary Motor Cortex | NEGATIVELY REGULATES | Action Potential Firing Threshold |
| Action Potential Firing Threshold | AMELIORATES | Seizure |
| Seizure | CAUSED BY | Lennox-Gastaut Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00252#mechanismofaction](https://go.drugbank.com/drugs/DB00252#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin](https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin)
